• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于诊断威尔逊病的计算参数。

Calculated parameters for the diagnosis of Wilson disease.

机构信息

Chemical Pathology Unit, Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Singapore Med J. 2023 Mar;64(3):188-195. doi: 10.11622/smedj.2022019. Epub 2022 Feb 10.

DOI:10.11622/smedj.2022019
PMID:35139628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10071855/
Abstract

INTRODUCTION

The diagnosis of Wilson disease (WD) is plagued by biochemical and clinical uncertainties. Thus, calculated parameters have been proposed. This study aimed to: (a) compare the diagnostic values of non-caeruloplasmin copper (NCC), NCC percentage (NCC%), copper-caeruloplasmin ratio (CCR) and adjusted copper in WD; and (b) derive and evaluate a discriminant function in diagnosing WD.

METHODS

A total of 213 subjects across all ages who were investigated for WD were recruited. WD was confirmed in 55 patients, and the rest were WD free. Based on serum copper and caeruloplasmin values, NCC, NCC%, CCR and adjusted copper were calculated for each subject. A function was derived using discriminant analysis, and the cut-off value was determined through receiver operating characteristic analysis. Classification accuracy was found by cross-tabulation.

RESULTS

Caeruloplasmin, total copper, NCC, NCC%, CCR, adjusted copper and discriminant function were significantly lower in WD compared to non-WD. Discriminant function showed the best diagnostic specificity (99.4%), sensitivity (98.2%) and classification accuracy (99.1%). Caeruloplasmin levels <0.14 g/L showed higher accuracy than the recommended 0.20 g/L cut-off value (97.7% vs. 87.8%). Similarly, molar NCC below the European cut-off of 1.6 umol/L showed higher accuracy than the American cut-off of 3.9 umol/L (80.3% vs. 59.6%) (P < 0.001). NCC%, mass NCC, CCR and adjusted copper showed poorer performances.

CONCLUSION

Discriminant function differentiates WD from non-WD with excellent specificity, sensitivity and accuracy. Performance of serum caeruloplasmin <0.14 g/L was better than that of <0.20 g/L. NCC, NCC%, CCR and adjusted copper are not helpful in diagnosing WD.

摘要

介绍

威尔逊病(WD)的诊断受到生化和临床不确定性的困扰。因此,已经提出了一些计算参数。本研究旨在:(a)比较非铜蓝蛋白铜(NCC)、NCC 百分比(NCC%)、铜-铜蓝蛋白比值(CCR)和调整后的铜在 WD 中的诊断价值;(b)推导并评估诊断 WD 的判别函数。

方法

共招募了 213 名年龄各异的 WD 研究对象。55 例患者确诊为 WD,其余为 WD 阴性。根据血清铜和铜蓝蛋白值,计算每位患者的 NCC、NCC%、CCR 和调整后的铜。使用判别分析推导函数,并通过接收者操作特征分析确定截断值。通过交叉制表确定分类准确性。

结果

与非 WD 相比,WD 患者的铜蓝蛋白、总铜、NCC、NCC%、CCR、调整后的铜和判别函数明显较低。判别函数的诊断特异性(99.4%)、敏感性(98.2%)和分类准确性(99.1%)最高。铜蓝蛋白水平<0.14 g/L 的准确性高于推荐的 0.20 g/L 截断值(97.7%比 87.8%)。同样,摩尔 NCC 低于欧洲截断值 1.6 umol/L 的准确性高于美国截断值 3.9 umol/L(80.3%比 59.6%)(P<0.001)。NCC%、质量 NCC、CCR 和调整后的铜的性能较差。

结论

判别函数可以很好地区分 WD 和非 WD,具有极好的特异性、敏感性和准确性。血清铜蓝蛋白<0.14 g/L 的性能优于<0.20 g/L。NCC、NCC%、CCR 和调整后的铜无助于诊断 WD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083e/10071855/7a0062503226/SMJ-64-188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083e/10071855/bf32da213571/SMJ-64-188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083e/10071855/12eef8317822/SMJ-64-188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083e/10071855/7a0062503226/SMJ-64-188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083e/10071855/bf32da213571/SMJ-64-188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083e/10071855/12eef8317822/SMJ-64-188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/083e/10071855/7a0062503226/SMJ-64-188-g003.jpg

相似文献

1
Calculated parameters for the diagnosis of Wilson disease.用于诊断威尔逊病的计算参数。
Singapore Med J. 2023 Mar;64(3):188-195. doi: 10.11622/smedj.2022019. Epub 2022 Feb 10.
2
Biomarkers for diagnosis of Wilson's disease.用于诊断威尔逊氏病的生物标志物。
Cochrane Database Syst Rev. 2019 Nov 19;2019(11):CD012267. doi: 10.1002/14651858.CD012267.pub2.
3
Copper:caeruloplasmin ratio.铜:血浆铜蓝蛋白比值
J Clin Pathol. 2007 Apr;60(4):441-2. doi: 10.1136/jcp.2006.041756.
4
Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.在常规临床实践中根据血浆铜蓝蛋白水平调整铜浓度。
J Clin Pathol. 2006 Aug;59(8):867-9. doi: 10.1136/jcp.2005.034876. Epub 2006 Apr 27.
5
Is it necessary to re-evaluate diagnostic criteria for Wilson disease in children?是否有必要重新评估儿童威尔逊病的诊断标准?
Turk J Gastroenterol. 2014 Dec;25(6):690-5. doi: 10.5152/tjg.2014.7787.
6
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets.临床稳定的威尔逊病患者的非铜蓝蛋白铜和尿铜:与推荐目标的一致性。
JHEP Rep. 2024 May 6;6(8):101115. doi: 10.1016/j.jhepr.2024.101115. eCollection 2024 Aug.
7
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.三乙膦酸氢钾盐与青霉胺用于肝豆状核变性(CHELATE)维持治疗的比较:一项随机、开放标签、非劣效性、3 期临床试验。
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1092-1102. doi: 10.1016/S2468-1253(22)00270-9. Epub 2022 Sep 30.
8
Efficacy of Different Diagnostic Test for Identifying Wilson's Disease.不同诊断试验在诊断 Wilson 病中的效能。
Mymensingh Med J. 2022 Jan;31(1):117-123.
9
[The diagnostic value and limits of diagnostic parameters for Wilson's disease].[肝豆状核变性诊断参数的诊断价值及局限性]
Zhonghua Gan Zang Bing Za Zhi. 2017 Dec 20;25(12):881-885. doi: 10.3760/cma.j.issn.1007-3418.2017.12.001.
10
[Phenotypes and ATP7B gene variants in 316 children with Wilson disease].316例肝豆状核变性患儿的表型与ATP7B基因变异
Zhonghua Er Ke Za Zhi. 2022 Apr 2;60(4):317-322. doi: 10.3760/cma.j.cn112140-20210827-00708.

引用本文的文献

1
Wilson's Disease with Acute Hepatic Onset: How to Diagnose and Treat It.急性肝起病型威尔逊病:如何诊断与治疗
Children (Basel). 2024 Jan 6;11(1):68. doi: 10.3390/children11010068.
2
Monitoring of Copper in Wilson Disease.威尔逊病中铜的监测
Diagnostics (Basel). 2023 May 23;13(11):1830. doi: 10.3390/diagnostics13111830.
3
Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests.威尔逊病与α1-抗胰蛋白酶缺乏症:非侵入性诊断测试综述

本文引用的文献

1
Wilson's disease: A 2017 update.肝豆状核变性:2017 年更新版
Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):512-520. doi: 10.1016/j.clinre.2018.03.007. Epub 2018 Apr 4.
2
Free copper in serum: An analytical challenge and its possible applications.血清游离铜:分析挑战及其可能的应用。
J Trace Elem Med Biol. 2018 Jan;45:176-180. doi: 10.1016/j.jtemb.2017.11.006. Epub 2017 Nov 8.
3
The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.计算得出的非铜蓝蛋白结合铜在威尔逊病中的作用。
Diagnostics (Basel). 2023 Jan 10;13(2):256. doi: 10.3390/diagnostics13020256.
Ann Clin Biochem. 2017 Nov;54(6):649-654. doi: 10.1177/0004563216676843. Epub 2016 Oct 13.
4
Multivariable discriminant analysis for the differential diagnosis of microcytic anemia.用于小细胞贫血鉴别诊断的多变量判别分析
Anemia. 2013;2013:457834. doi: 10.1155/2013/457834. Epub 2013 Sep 4.
5
EASL Clinical Practice Guidelines: Wilson's disease.EASL 临床实践指南:肝豆状核变性。
J Hepatol. 2012 Mar;56(3):671-85. doi: 10.1016/j.jhep.2011.11.007.
6
Direct measurement of free copper in serum or plasma ultrafiltrate.血清或血浆超滤液中游离铜的直接测量。
Am J Clin Pathol. 2009 Feb;131(2):160-5. doi: 10.1309/AJCP7Z9KBFINVGYF.
7
Diagnostic accuracy of serum ceruloplasmin in Wilson disease: determination of sensitivity and specificity by ROC curve analysis among ATP7B-genotyped subjects.血清铜蓝蛋白在肝豆状核变性诊断中的准确性:通过ATP7B基因分型受试者的ROC曲线分析确定敏感性和特异性
Clin Chem. 2008 Aug;54(8):1356-62. doi: 10.1373/clinchem.2008.103432. Epub 2008 Jun 12.
8
Diagnosis and treatment of Wilson disease: an update.威尔逊病的诊断与治疗:最新进展
Hepatology. 2008 Jun;47(6):2089-111. doi: 10.1002/hep.22261.
9
Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories.不同实验室常规临床实践中的非铜蓝蛋白结合铜
J Trace Elem Med Biol. 2008;22(1):50-3. doi: 10.1016/j.jtemb.2007.11.001. Epub 2008 Feb 19.
10
Percentage non-caeruloplasmin bound copper.非铜蓝蛋白结合铜的百分比。
Clin Biochem. 2007 Jun;40(9-10):749-50. doi: 10.1016/j.clinbiochem.2007.04.002. Epub 2007 Apr 19.